C

Celyad

109 employees

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

Basic info

Industry

biotechnology

Sectors

Medical Device
Biotechnology
Therapeutics
Immuno-Oncology
Immnotherapy
Natural Killer Receptors
Cancer

Date founded

2007

Funding rounds raised

Total raised

$32M

from 7 investors over 7 rounds

C

Celyad raised $32M on December 3, 2021

Investors: Fortress Investment Group

C

Celyad raised $25M on May 8, 2013

Investors: Hunza Ventures

C

Celyad raised $9.5M on January 19, 2009

Investors: Hunza Ventures, Life Sciences Research Partners vzw and Grifols

C

Celyad raised undisclosed on August 31, 2007

Investors: SRIW and -

FAQ